NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 23 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $10,000 | -75.6% | 21,257 | -51.8% | 0.00% | – |
| Q1 2022 | $41,000 | -25.5% | 44,087 | -2.4% | 0.00% | – |
| Q4 2021 | $55,000 | -66.9% | 45,194 | +1.4% | 0.00% | – |
| Q3 2021 | $166,000 | -0.6% | 44,579 | -11.3% | 0.00% | – |
| Q2 2021 | $167,000 | -83.2% | 50,268 | -77.8% | 0.00% | – |
| Q1 2021 | $995,000 | -13.8% | 226,013 | +2.7% | 0.00% | – |
| Q4 2020 | $1,154,000 | -2.0% | 219,989 | +5.0% | 0.00% | – |
| Q3 2020 | $1,177,000 | -30.0% | 209,507 | +0.3% | 0.00% | – |
| Q2 2020 | $1,682,000 | +369.8% | 208,912 | +710.3% | 0.00% | – |
| Q1 2020 | $358,000 | +58.4% | 25,783 | 0.0% | 0.00% | – |
| Q4 2019 | $226,000 | – | 25,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $191,000 | 0.02% |
| FNY Investment Advisers, LLC | 10,000 | $33,000 | 0.01% |
| SG3 Management, LLC | 50,000 | $167,000 | 0.01% |
| PITCAIRN CO | 12,351 | $41,000 | 0.00% |
| Ergoteles LLC | 30,800 | $103,000 | 0.00% |
| Advisory Services Network, LLC | 8,550 | $28,000 | 0.00% |
| HRT FINANCIAL LP | 18,759 | $62,000 | 0.00% |
| UBS Group AG | 2,881 | $10,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1,062 | $4,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 320 | $1,000 | 0.00% |